These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10975014)

  • 21. Regulatory T cells, Cytotoxic T lymphocytes and a T(H)1 cytokine profile in dogs naturally infected by Leishmania infantum.
    Cortese L; Annunziatella M; Palatucci AT; Rubino V; Piantedosi D; Di Loria A; Ruggiero G; Ciaramella P; Terrazzano G
    Res Vet Sci; 2013 Dec; 95(3):942-9. PubMed ID: 24079840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of serum antibodies against Leishmania 94 kDa antigen in visceral and cutaneous leishmaniosis due to Leishmania infantum.
    Rolland L; Belkaid M; Seye A; Schneider P; Gentilini M
    Parasite; 1995 Mar; 2(1):13-21. PubMed ID: 9137640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis.
    Carrillo E; Crusat M; Nieto J; Chicharro C; Thomas Mdel C; Martínez E; Valladares B; Cañavate C; Requena JM; López MC; Alvar J; Moreno J
    Vaccine; 2008 Mar; 26(15):1902-11. PubMed ID: 18321614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leishmania-specific isotype levels and their relationship with specific cell-mediated immunity parameters in canine leishmaniasis.
    Rodríguez-Cortés A; Fernández-Bellón H; Ramis A; Ferrer L; Alberola J; Solano-Gallego L
    Vet Immunol Immunopathol; 2007 Apr; 116(3-4):190-8. PubMed ID: 17321600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation of Leishmania infantum seropositivity in HIV/AIDS patients].
    Ozkan AT; Yalçinkaya T; Kiliç S; Babür C; Schallig HD
    Mikrobiyol Bul; 2008 Jan; 42(1):113-7. PubMed ID: 18444568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with Trichinella spirallis antigens increases CD8+ peripheral T cells and enhances the Th2 immune response in Leishmania infantum challenged mice.
    Daoudaki M; Diakou A; Frydas S; Fouzas I; Karagouni E; Vavatsi N; Haralabidis S
    Int J Immunopathol Pharmacol; 2009; 22(1):169-74. PubMed ID: 19309564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for subclinical Leishmania infection in HIV-infected patients living in eastern Spain.
    Ena J; Pasquau F; del Mar López-Perezagua M; Martinez-Peinado C; Arjona F
    Pathog Glob Health; 2014 Dec; 108(8):356-61. PubMed ID: 25468205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination with Leishmania infantum acidic ribosomal P0 but not with nucleosomal histones proteins controls Leishmania infantum infection in hamsters.
    Pereira L; Abbehusen M; Teixeira C; Cunha J; Nascimento IP; Fukutani K; dos-Santos W; Barral A; de Oliveira CI; Barral-Netto M; Soto M; Brodskyn CI
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003490. PubMed ID: 25642946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy.
    Moreno J; Nieto J; Chamizo C; González F; Blanco F; Barker DC; Alvar J
    Vet Immunol Immunopathol; 1999 Nov; 71(3-4):181-95. PubMed ID: 10587300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
    Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients.
    García-García JA; Martín-Sánchez J; Gállego M; Rivero-Román A; Camacho A; Riera C; Morillas-Márquez F; Vergara S; Macías J; Pineda JA
    J Clin Microbiol; 2006 Dec; 44(12):4455-8. PubMed ID: 17050814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of intracellular IFN-γ and IL-4 cytokines in CD4+ and CD8+ T cells in the peripheral blood of dogs naturally infected with Leishmania infantum.
    Matralis D; Papadogiannakis E; Kontos V; Papadopoulos E; Ktenas E; Koutinas A
    Parasite Immunol; 2016 Aug; 38(8):510-5. PubMed ID: 27153749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection.
    Ribeiro PAF; Dias DS; Lage DP; Martins VT; Costa LE; Santos TTO; Ramos FF; Tavares GSV; Mendonça DVC; Ludolf F; Gomes DA; Rodrigues MA; Chávez-Fumagalli MA; Silva ES; Galdino AS; Duarte MC; Roatt BM; Menezes-Souza D; Teixeira AL; Coelho EAF
    Mol Immunol; 2019 Feb; 106():108-118. PubMed ID: 30594673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides.
    Agallou M; Pantazi E; Tsiftsaki E; Toubanaki DK; Gaitanaki C; Smirlis D; Karagouni E
    Mol Immunol; 2018 Nov; 103():7-20. PubMed ID: 30173073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
    Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
    Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
    Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological profile of resistance and susceptibility in naturally infected dogs by Leishmania infantum.
    de Almeida Leal GG; Roatt BM; de Oliveira Aguiar-Soares RD; Carneiro CM; Giunchetti RC; Teixeira-Carvalho A; Martins-Filho OA; Francisco AF; Cardoso JM; Mathias FA; Correa-Oliveira R; Carneiro M; Coura-Vital W; Reis AB
    Vet Parasitol; 2014 Oct; 205(3-4):472-82. PubMed ID: 25234767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seroprevalence of Leishmania infection and molecular detection of Leishmania tropica and Leishmania infantum in stray cats of İzmir, Turkey.
    Can H; Döşkaya M; Özdemir HG; Şahar EA; Karakavuk M; Pektaş B; Karakuş M; Töz S; Caner A; Döşkaya AD; İz SG; Özbel Y; Gürüz Y
    Exp Parasitol; 2016 Aug; 167():109-14. PubMed ID: 27260567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leishmania infantum amastigotes trigger a subpopulation of human B cells with an immunoregulatory phenotype.
    Andreani G; Ouellet M; Menasria R; Gomez AM; Barat C; Tremblay MJ
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003543. PubMed ID: 25710789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.